Totally agree with your sentiments Intowin.
Prima's projected revenue statements are based on 10% of the current ovarian cancer market. In reality, if (when) pivotal phase 3 trials are successful, this will be a very conservative projection in the early years.
There is plenty of room for'competitors',who in all likely hood will not be competitors at all due to the many and various mutations of cancer, which one drug/therapy could never possibly treat.
- Forums
- ASX - By Stock
- olaparib
Totally agree with your sentiments Intowin.Prima's projected...
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
(20min delay)
|
|||||
Last
31.0¢ |
Change
-0.005(1.59%) |
Mkt cap ! $450.9M |
Open | High | Low | Value | Volume |
31.5¢ | 31.8¢ | 31.0¢ | $897.5K | 2.872M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
9 | 79201 | 31.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.5¢ | 138883 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
9 | 79201 | 0.310 |
18 | 240613 | 0.305 |
26 | 668636 | 0.300 |
7 | 138083 | 0.295 |
11 | 229590 | 0.290 |
Price($) | Vol. | No. |
---|---|---|
0.315 | 138883 | 3 |
0.320 | 47330 | 2 |
0.325 | 36000 | 2 |
0.330 | 199775 | 4 |
0.335 | 196676 | 5 |
Last trade - 16.10pm 08/10/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |